Monopar Expands Phase 2b/3 VOICE Clinical Trial to Europe

NEXT STORY
Outlook Therapeutics Presents Positive NORSE THREE Safety Data for ONS-5010 / LYTENAVA™ (bevacizumab-vikg) at EURETINA Virtual 2021 Medical Conference
PREV STORY
PolyPid Announces Positive Preclinical Data of its Intra-tumoral OncoPLEX in Brain Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

argenx announces first patient dosed in Phase II proof-of-concept study of ARGX-113 for the treatment of primary immune thrombocytopenia

-Topline data from the study expected in second half of 2018- 31 March 2017 ...

author_avatar
NASDAQ Market News

Global Precision Medicine Market Report 2017-2026

Dublin, Oct. 24, 2017 (GLOBE NEWSWIRE) -- The "Global Precision Medicine Market" report has ...

author_avatar
NASDAQ Market News

Diet Doc Specializes in Weight Control and Helps People Nationwide Take Charge of Their Health and Control, or Even Prevent Diabetes through Safe, Comfortable and Fast Weight Loss

HOUSTON, Dec. 4, 2015 (GLOBE NEWSWIRE) -- Most people understand that carrying extra weight, ...

author_avatar
NASDAQ Market News